Ramelteon as an Adjunct Therapy in Non-Diabetic Patients With Schizophrenia

PHASE4CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions
SchizophreniaSchizoaffective DisorderSchizophreniform Disorders
Interventions
DRUG

Ramelteon

Two week supply of ramelteon 8mg/day first dispensed at baseline. New two week supply of study medication dispensed at each biweekly visit for 8 consecutive weeks.

DRUG

Placebo

Two week supply of placebo tablets first dispensed at baseline. New two week supply of placebo dispensed at each biweekly visit for 8 consecutive weeks.

Trial Locations (1)

02114

Freedom Trail Clinic, Boston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Takeda

INDUSTRY

lead

Massachusetts General Hospital

OTHER